昭衍新药
(603127)
| 流通市值：238.70亿 | | | 总市值：283.75亿 |
| 流通股本：6.30亿 | | | 总股本：7.49亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 662,232,173.6 | 676,571,156.45 | 965,203,128.59 | 1,840,124,511.87 |
| 交易性金融资产 | 1,503,832,762.56 | 1,495,071,027.91 | 1,396,123,348.18 | 1,382,197,887.15 |
| 应收票据及应收账款 | 187,032,668.78 | 198,669,231.02 | 218,002,950.36 | 228,563,668.14 |
| 其中：应收票据 | 27,877,996.51 | 19,757,152.34 | 36,835,066.37 | 15,521,997.9 |
| 应收账款 | 159,154,672.27 | 178,912,078.68 | 181,167,883.99 | 213,041,670.24 |
| 预付款项 | 24,052,384.62 | 66,473,403.33 | 63,603,854.58 | 93,367,592.03 |
| 其他应收款合计 | 7,285,709.55 | 8,170,222.64 | 8,488,030.66 | 11,307,419.49 |
| 存货 | 1,560,968,955.1 | 1,528,404,534.7 | 1,478,547,177.81 | 1,631,793,427.45 |
| 合同资产 | 93,231,641.26 | 104,715,217.02 | 121,996,566.95 | 101,229,555.78 |
| 一年内到期的非流动资产 | 1,187,478,933.82 | 940,288,560.33 | 729,846,540.9 | - |
| 其他流动资产 | 53,837,557.17 | 45,397,734.18 | 49,386,329.35 | 45,527,967.05 |
| 流动资产合计 | 5,279,952,786.46 | 5,063,761,087.58 | 5,031,197,927.38 | 5,334,112,028.96 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 91,000,000 | 91,000,000 | 91,000,000 | 159,840,000 |
| 其他非流动金融资产 | 683,833,974.72 | 631,009,195.44 | 624,973,939.54 | 614,027,609.91 |
| 固定资产 | 790,959,184.92 | 677,345,597.14 | 696,785,630.77 | 669,976,461.06 |
| 在建工程 | 286,538,078.69 | 394,629,147.57 | 368,927,206.62 | 323,645,798.21 |
| 生产性生物资产 | 376,212,526.95 | 373,378,624.23 | 383,304,545.59 | 393,069,851.01 |
| 使用权资产 | 35,209,874.97 | 44,254,815.65 | 52,612,530.54 | 64,522,594.94 |
| 无形资产 | 290,546,105.12 | 294,694,673.84 | 298,514,374.33 | 294,064,206.17 |
| 商誉 | 137,464,564.69 | 137,840,937.93 | 138,036,805.64 | 134,561,113.99 |
| 长期待摊费用 | 70,152,998.74 | 60,165,649.02 | 63,055,662.45 | 67,282,378.5 |
| 递延所得税资产 | 29,438,853.06 | 33,995,873.85 | 33,356,441.14 | 39,181,770.56 |
| 其他非流动资产 | 1,402,153,313.98 | 1,622,583,007.27 | 1,614,387,546.45 | 1,430,900,994.67 |
| 非流动资产合计 | 4,193,509,475.84 | 4,360,897,521.94 | 4,364,954,683.07 | 4,191,072,779.02 |
| 资产总计 | 9,473,462,262.3 | 9,424,658,609.52 | 9,396,152,610.45 | 9,525,184,807.98 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 52,821,291.98 | 44,537,300.58 | 50,222,333.86 | 39,305,320.91 |
| 应付账款 | 52,821,291.98 | 44,537,300.58 | 50,222,333.86 | 39,305,320.91 |
| 合同负债 | 896,149,406.79 | 871,306,662.06 | 827,161,128.2 | 1,064,046,398.38 |
| 应付职工薪酬 | 78,177,192.38 | 63,929,189.33 | 103,371,485.37 | 82,520,776.76 |
| 应交税费 | 10,956,908.69 | 14,419,001.11 | 23,800,985.71 | 8,611,739.52 |
| 其他应付款合计 | 95,682,870.92 | 68,160,052.25 | 62,647,485.54 | 62,202,411.21 |
| 应付股利 | 22,385,229 | - | - | - |
| 一年内到期的非流动负债 | 30,394,935.5 | 32,120,462.57 | 39,373,610.5 | 38,697,752.54 |
| 其他流动负债 | 2,965,834.25 | 3,186,695.53 | 3,991,567.1 | 3,322,471.24 |
| 流动负债合计 | 1,167,148,440.51 | 1,097,659,363.43 | 1,110,568,596.28 | 1,298,706,870.56 |
| 非流动负债: | | | | |
| 租赁负债 | 10,176,338.01 | 20,996,748.83 | 21,599,642.95 | 32,771,963.22 |
| 递延收益 | 76,845,177.89 | 79,606,862.99 | 67,920,688.55 | 69,616,218.99 |
| 递延所得税负债 | 114,225,830.16 | 117,189,711.21 | 116,875,428.71 | 133,255,156.98 |
| 非流动负债合计 | 201,247,346.06 | 217,793,323.03 | 206,395,760.21 | 235,643,339.19 |
| 负债合计 | 1,368,395,786.57 | 1,315,452,686.46 | 1,316,964,356.49 | 1,534,350,209.75 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 749,477,334 | 749,477,334 | 749,477,334 | 749,477,334 |
| 资本公积 | 5,237,665,882.34 | 5,237,665,882.34 | 5,237,665,882.34 | 5,250,020,019.41 |
| 减:库存股 | 230,898,376.4 | 230,898,376.4 | 220,563,519.61 | 211,100,000.16 |
| 其他综合收益 | 47,142,984.16 | 48,710,113.62 | 49,477,052.98 | 95,658,951.64 |
| 盈余公积 | 167,792,770.8 | 167,792,770.8 | 167,792,770.8 | 144,259,244.76 |
| 未分配利润 | 2,133,516,236.58 | 2,136,088,558.44 | 2,094,969,066.21 | 1,974,120,132.55 |
| 归属于母公司股东权益合计 | 8,104,696,831.48 | 8,108,836,282.8 | 8,078,818,586.72 | 8,002,435,682.2 |
| 少数股东权益 | 369,644.25 | 369,640.26 | 369,667.24 | -11,601,083.97 |
| 股东权益合计 | 8,105,066,475.73 | 8,109,205,923.06 | 8,079,188,253.96 | 7,990,834,598.23 |
| 负债和股东权益合计 | 9,473,462,262.3 | 9,424,658,609.52 | 9,396,152,610.45 | 9,525,184,807.98 |
| 公告日期 | 2025-08-27 | 2025-04-29 | 2025-03-29 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |